Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H3 | Q13133 | 4/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.47 |
| ▸ | AVPR1B | P47901 | 9/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TGM2 | P21980 | 1/20 | 0.36 |
| ▸ | TGM1 | P22735 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6578727 | 0.96 | NR1H2 (0.43) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6584155 | 0.87 | NR1H3 (0.51) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6581092 | 0.87 | NR1H2 (0.45) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6584148 | 0.86 | NR1H3 (0.48) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6578548 | 0.85 | NR1H3 (0.64) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6584100 | 0.84 | NR1H2 (0.48) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6581065 | 0.84 | NR1H3 (0.48) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6578958 | 0.84 | NR1H3 (0.48) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6580723 | 0.83 | NR1H2 (0.47) | NR1H3NR1H2AVPR1BNPC1RAB9A | |
| SCHEMBL6581091 | 0.83 | NR1H3 (0.71) | NR1H3NR1H2NPC1RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1070708-B1 | Triazole derivatives | HOFFMANN LA ROCHE (CH) | 2004-01-14 | — | — | EP | disclosed |
| US-6265426-B1 | CENTRAL NERVOUS SYSTEM DISORDERS | HOFFMANN-LA ROCHE INC. | 2001-07-24 | — | — | US | disclosed |
| EP-1070708-A1 | Triazole and imidazole derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2001-01-24 | — | — | EP | disclosed |